Therapeutic antibodies – natural and pathological barriers and strategies to overcome them

Antibody-based therapeutics have become a major class of therapeutics with over 120 recombinant antibodies approved or under review in the EU or US. This therapeutic class has experienced a remarkable expansion with an expected acceleration in 2021–2022 due to the extraordinary global response to SA...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Ojaimi, Yara, Blin, Timothée, Lamamy, Juliette, Gracia, Matthieu, Pitiot, Aubin, Denevault-Sabourin, Caroline, Joubert, Nicolas, Pouget, Jean-Pierre, Gouilleux-Gruart, Valérie, Heuzé-Vourc’h, Nathalie, Lanznaster, Débora, Poty, Sophie, Sécher, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Invited Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527648/
https://www.ncbi.nlm.nih.gov/pubmed/34687769
http://dx.doi.org/10.1016/j.pharmthera.2021.108022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527648/
https://www.ncbi.nlm.nih.gov/pubmed/34687769
http://dx.doi.org/10.1016/j.pharmthera.2021.108022

Ejemplares similares